GlassScriptPhysician profile
Nancy Toll
NPI 1023616992
$805.79
in general payments reported to CMS, 2019-2025
13 companies · $94.18 in 2025
The $94.18 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.08 · 2023: $617 · 2025: $94.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $164.62 | 2023 | |
| Amgen INC. | $133.63 | 2023 | Repatha, Prolia, Evenity |
| Novo Nordisk INC | $108.18 | 2021-2023 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $100.86 | 2023 | Abilify Maintena |
| Organon LLC | $94.18 | 2025 | Nexplanon |
| Glaxosmithkline, LLC. | $67.78 | 2023 | Trelegy Ellipta |
| Lilly USA, LLC | $43.14 | 2023 | Jardiance, Emgality |
| Pfizer INC. | $23.22 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.31 | 2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $15.70 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.57 | 2023 | Xifaxan |
| Medtronic, INC. | $13.30 | 2023 | Vanta Adaptivestim |
| Corium, LLC | $6.30 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Toll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.